Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail
  • Print
  • Share
  • E-mail
-
 
Pediatric Labeling Date:  01/18/2011
 
Trade Name:  Natroba
 
Generic Name or Proper Name (*):  spinosad
 
Indications Studied:  Treatment of head lice infestation in patients 4 years of age and older
 
Label Changes Summary:  Safety and effectiveness have been established in pediatric patients 4 years of age and older Safety in pediatric patients < 4 years has not been established. Not recommended in pediatric patients< 6 months because of the potential for increased systemic absorptionNatroba contains benzyl alcohol which has been associated with serious adverse reactions and death in neonates and low birth-weight infants. Premature and low-birth weight infants, as well as patients receiving high dosages, may be more likely to develop toxicityInformation on clinical trials, adverse reactionsNew drug
 
Product Labeling:  Labeling  Opens a new window
 
PREA(P):  P
 
Sponsor:  ParaPRO
 
NNPS:  FALSE'
 
Therapeutic Category:  Pediculocide, topical
 
-
-